Stockreport

Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock

Standard BioTools Inc.  (LAB) 
PDF SOUTH SAN FRANCISCO, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it has [Read more]